Your browser doesn't support javascript.
loading
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model.
Lau, Sai Ping; van Montfoort, Nadine; Kinderman, Priscilla; Lukkes, Melanie; Klaase, Larissa; van Nimwegen, Menno; van Gulijk, Mandy; Dumas, Jasper; Mustafa, Dana A M; Lievense, Sanne L A; Groeneveldt, Christianne; Stadhouders, Ralph; Li, Yunlei; Stubbs, Andrew; Marijt, Koen A; Vroman, Heleen; van der Burg, Sjoerd H; Aerts, Joachim; van Hall, Thorbald; Dammeijer, Floris; van Eijck, Casper H J.
Afiliação
  • Lau SP; Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van Montfoort N; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Kinderman P; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Lukkes M; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Klaase L; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van Nimwegen M; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van Gulijk M; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Dumas J; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Mustafa DAM; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Lievense SLA; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Groeneveldt C; Department of Pulmonary Medicine, Amphia Hospital, Breda, The Netherlands.
  • Stadhouders R; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Li Y; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Stubbs A; Department of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Marijt KA; Clinical Bioinformatics Unit, Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Vroman H; Clinical Bioinformatics Unit, Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Aerts J; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Dammeijer F; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van Eijck CHJ; Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
J Immunother Cancer ; 8(2)2020 07.
Article em En | MEDLINE | ID: mdl-32690771
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Adenocarcinoma / Vacinas Anticâncer / Carcinoma Ductal Pancreático Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Adenocarcinoma / Vacinas Anticâncer / Carcinoma Ductal Pancreático Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda